A Case Series of TCR-T-cell therapy targeting PRAME in combination with BRAF-/MEK-inhibition in three melanoma patients with active CNS metastases

F Schmitz; K Epp; M Schumacher; Annkristin Heine; A Busch; M Heine; J Luan; K Wetzko; JA Luetkens; J Landsberg; E Livingstone; N Schäfer; R Zeiser; P Brossart; M Wermke; TA Holderried

A Case Series of TCR-T-cell therapy targeting PRAME in combination with BRAF-/MEK-inhibition in three melanoma patients with active CNS metastases

F Schmitz
, K Epp
, M Schumacher
, Annkristin Heine
, A Busch
, M Heine
, J Luan
, K Wetzko
, JA Luetkens
, J Landsberg
, E Livingstone
, N Schäfer
, R Zeiser
, P Brossart
, M Wermke
, TA Holderried

Division of Haematology

Research output: Contribution to journal › Conference abstract

Original language	English
Journal	Oncology Research and Treatment
Publication status	Published - 2025
Event	Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie - Cologne, Germany Duration: 24 Oct 2025 → 27 Oct 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Links

Web of Science

A Case Series of TCR-T-cell therapy targeting PRAME in combination with BRAF-/MEK-inhibition in three melanoma patients with active CNS metastases
Schmitz, F. (Author), Epp, K. (Author), Schumacher, M. (Author), Heine, A. (Author), Busch, A. (Author), Heine, M. (Author), Luan, J. (Author), Wetzko, K. (Author), Luetkens, J. (Author), Landsberg, J. (Author), Livingstone, E. (Author), Schäfer, N. (Author), Zeiser, R. (Author), Brossart, P. (Author), Wermke, M. (Author) & Holderried, T. (Author)
2025
Activity: Talk, presentation or poster › Poster

Cite this

Schmitz, F., Epp, K., Schumacher, M., Heine, A., Busch, A., Heine, M., Luan, J., Wetzko, K., Luetkens, JA., Landsberg, J., Livingstone, E., Schäfer, N., Zeiser, R., Brossart, P., Wermke, M., & Holderried, TA. (2025). A Case Series of TCR-T-cell therapy targeting PRAME in combination with BRAF-/MEK-inhibition in three melanoma patients with active CNS metastases. Oncology Research and Treatment.

@article{ecf26df27e704c3eb03748eb4ef9b756,

title = "A Case Series of TCR-T-cell therapy targeting PRAME in combination with BRAF-/MEK-inhibition in three melanoma patients with active CNS metastases",

author = "F Schmitz and K Epp and M Schumacher and Annkristin Heine and A Busch and M Heine and J Luan and K Wetzko and JA Luetkens and J Landsberg and E Livingstone and N Sch{\"a}fer and R Zeiser and P Brossart and M Wermke and TA Holderried",

year = "2025",

language = "English",

journal = "Oncology Research and Treatment",

issn = "2296-5270",

publisher = "S. Karger AG",

note = "Jahrestagung der Deutschen, {\"O}sterreichischen und Schweizerischen Gesellschaften f{\"u}r H{\"a}matologie und Medizinische Onkologie ; Conference date: 24-10-2025 Through 27-10-2025",

}

Schmitz, F, Epp, K, Schumacher, M, Heine, A, Busch, A, Heine, M, Luan, J, Wetzko, K, Luetkens, JA, Landsberg, J, Livingstone, E, Schäfer, N, Zeiser, R, Brossart, P, Wermke, M & Holderried, TA 2025, 'A Case Series of TCR-T-cell therapy targeting PRAME in combination with BRAF-/MEK-inhibition in three melanoma patients with active CNS metastases', Oncology Research and Treatment.

TY - JOUR

T1 - A Case Series of TCR-T-cell therapy targeting PRAME in combination with BRAF-/MEK-inhibition in three melanoma patients with active CNS metastases

AU - Schmitz, F

AU - Epp, K

AU - Schumacher, M

AU - Heine, Annkristin

AU - Busch, A

AU - Heine, M

AU - Luan, J

AU - Wetzko, K

AU - Luetkens, JA

AU - Landsberg, J

AU - Livingstone, E

AU - Schäfer, N

AU - Zeiser, R

AU - Brossart, P

AU - Wermke, M

AU - Holderried, TA

PY - 2025

Y1 - 2025

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:1639100700428

M3 - Conference abstract

SN - 2296-5270

JO - Oncology Research and Treatment

JF - Oncology Research and Treatment

T2 - Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie

Y2 - 24 October 2025 through 27 October 2025

ER -

A Case Series of TCR-T-cell therapy targeting PRAME in combination with BRAF-/MEK-inhibition in three melanoma patients with active CNS metastases

UN SDGs

Links

Activities

A Case Series of TCR-T-cell therapy targeting PRAME in combination with BRAF-/MEK-inhibition in three melanoma patients with active CNS metastases

Cite this